Two Sigma Investments’s Enfusion, Inc. ENFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-55,595
Closed -$514K 3403
2024
Q1
$514K Buy
55,595
+23,606
+74% +$208K ﹤0.01% 2318
2023
Q4
$310K Sell
31,989
-8,006
-20% -$74.8K ﹤0.01% 2682
2023
Q3
$359K Sell
39,995
-252,711
-86% -$2.4M ﹤0.01% 2423
2023
Q2
$3.28M Sell
292,706
-66,167
-18% -$587K 0.01% 1136
2023
Q1
$3.77M Buy
358,873
+333,104
+1,293% +$3.67M 0.01% 1047
2022
Q4
$249K Buy
+25,769
New +$290K ﹤0.01% 2316

Other funds holding ENFN

Two Sigma Investments's ENFN Position: Q2 2024 in Review

Two Sigma Investments sold out of Enfusion, Inc. (ENFN) in Q2 2024, closing a stake of 55,595 shares — an estimated $514K sold.

Two Sigma Investments first reported a position in ENFN in Q4 2022 and held it in 6 quarters. The position peaked at $3.77M in Q1 2023. 101 funds tracked by Wall St. Rank hold ENFN as of Q2 2024.

  • Two Sigma Investments reported no remaining Enfusion, Inc. position as of Q2 2024 after selling out during the quarter.
  • Two Sigma Investments sold 55,595 Enfusion, Inc. shares in Q2 2024, an estimated $514K.
  • Two Sigma Investments first reported a position in Enfusion, Inc. in Q4 2022 and held it in 6 quarters.
  • Two Sigma Investments's Enfusion, Inc. position peaked at $3.77M in Q1 2023.
  • 101 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q2 2024.

Based on Two Sigma Investments's 13F filing for Q2 2024, filed 14 Aug 2024.